OAR@UM: Browsing OAR@UM

Browsing by Subject Antipsychotic drugs

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:

Showing results 15 to 34 of 39 < previous next >

Issue Date	Title	Author(s)
2004	Effect of acute antipsychotic administration on dopamine synthesis in rodents and human subjects using 6‐[18F]‐L‐m‐tyrosine	Mamo, David; Remington, Gary; Nobrega, Jose N.; Hussey, Doug; Chirakal, Raman; Wilson, Alan A.; Baker, Glen B.; Houle, Sylvain; Kapur, Shitij
2021	The effectiveness of quetiapine in improving behavioural and psychological symptoms in older adults with dementia	Xuereb, Crissel (2021)
2011	Effects of aging on 5‐HT2AR binding : a HRRT PET study with and without partial volume corrections	Uchida, Hiroyuki; Chow, Tiffany W.; Mamo, David; Kapur, Shitij; Mulsant, Benoit H.; Houle, Sylvain; Pollock, Bruce G.; Graff-Guerrero, Ariel
2013	Estimated dopamine D2 receptor occupancy and remission in schizophrenia : analysis of the CATIE data	Moriguchi, Sho; Bies, Robert R.; Remington, Gary; Suzuki, Takefumi; Mamo, David; Watanabe, Koichiro; Mimura, Masaru; Pollock, Bruce G.; Uchida, Hiroyuki
2016	Estimating the effect of endogenous dopamine on baseline [11C]‐(+)‐PHNO binding in the human brain	Caravaggio, Fernando; Kegeles, Lawrence S.; Wilson, Alan A.; Remington, Gary; Borlido, Carol; Mamo, David; Graff-Guerrero, Ariel
2012	Haloperidol for agitation in persons with dementia.	Debono, Michael
2016	Hearing voices : comparing the hearing voices approach with antipsychotic medication in adults	Micallef, Miriam
2006	High-dose quetiapine and photopsia	Hazra, Monica; Culo, Sandi; Mamo, David
2011	Impact of feedback from pharmacists in reducing antipsychotic polypharmacy in schizophrenia	Hazra, Monica; Uchida, Hiroyuki; Sproule, Beth A.; Remington, Gary; Suzuki, Takefumi; Mamo, David
2009	The intersection of pharmacology, imaging, and genetics in the development of personalized medicine	Gerretsen, Philip; Muller, Daniel J.; Tiwari, Arun; Mamo, David; Pollock, Bruce G.
2009	Long-term stability of measuring D 2 receptors in schizophrenia patients treated with antipsychotics	Uchida, Hiroyuki; Graff-Guerrero, Ariel; Mulsant, Benoit H.; Pollock, Bruce G.; Mamo, David
2004	A PET study of dopamine D2 and serotonin 5-HT2 receptor occupancy in patients with schizophrenia treated with therapeutic doses of ziprasidone	Mamo, David; Kapur, Shitij; Shammi, Chekkera M.; Papatheodorou, George; Mann, Steve; Therrien, Francois; Remington, Gary
2009	Predicting age‐specific dosing of antipsychotics	Uchida, Hiroyuki; Pollock, Bruce G.; Bies, Robert R.; Mamo, David
2012	Predicting plasma concentration of risperidone associated with dosage change : a population pharmacokinetic study	Uchida, Hiroyuki; Mamo, David; Pollock, Bruce G.; Suzuki, Takefumi; Tsunoda, Kenichi; Watanabe, Koichiro; Mimura, Masaru; Bies, Robert R.
2007	Quantification of l-stepholidine in rat brain and plasma by high performance liquid chromatography combined with fluorescence detection	Odontiadis, John; MacKenzie, Erin M.; Natesan, Sridhar; Mamo, David; Kapur, Shitij; Baker, Glen B.
2009	The relationship between subjective well-being and dopamine D2 receptors in patients treated with a dopamine partial agonist and full antagonist antipsychotics	Mizrahi, Romina; Mamo, David; Rusjan, Pablo; Graff, Ariel; Houle, Sylvain; Kapur, Shitij
2010	Role of serotonin in central dopamine dysfunction	Di Giovanni, Giuseppe; Esposito, Ennio; Di Matteo, Vincenzo
2010	Sensitivity to antipsychotic drugs in older adults	Leon, Chloe; Gerretsen, Philip; Uchida, Hiroyuki; Suzuki, Takefumi; Rajji, Tarek K.; Mamo, David
2015	Serotonergic modulation of the activity of mesencephalic dopaminergic systems : therapeutic implications	De Deurwaerdère, Philippe; Di Giovanni, Giuseppe
2008	Serotonin control of central dopaminergic function : focus on in vivo microdialysis studies	Di Matteo, Vincenzo; Di Giovanni, Giuseppe; Pierucci, Massimo; Esposito, Ennio

Showing results 15 to 34 of 39 < previous next >